Improving Health Outcomes

Cancer Care in the Deep South

Circulating tumor DNA may hold earlier answers about treatment response

Can circulating tumor DNA be used to screen for cancer?

Liquid biopsy predicts response to breast cancer immunotherapy

This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine.

Genomic testing finds a higher prevalence of high-risk breast cancer in Black women

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.